464 related articles for article (PubMed ID: 25609773)
1. Myocardial fibrosis and pro-fibrotic markers in end-stage heart failure patients during continuous-flow left ventricular assist device support.
Lok SI; Nous FM; van Kuik J; van der Weide P; Winkens B; Kemperman H; Huisman A; Lahpor JR; de Weger RA; de Jonge N
Eur J Cardiothorac Surg; 2015 Sep; 48(3):407-15. PubMed ID: 25609773
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin: a potential biomarker for heart failure and reverse remodeling after left ventricular assist device support.
Schipper ME; Scheenstra MR; van Kuik J; van Wichen DF; van der Weide P; Dullens HF; Lahpor J; de Jonge N; De Weger RA
J Heart Lung Transplant; 2011 Jul; 30(7):805-10. PubMed ID: 21531579
[TBL] [Abstract][Full Text] [Related]
3. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device.
Bruggink AH; de Jonge N; van Oosterhout MF; Van Wichen DF; de Koning E; Lahpor JR; Kemperman H; Gmelig-Meyling FH; de Weger RA
J Heart Lung Transplant; 2006 Feb; 25(2):174-80. PubMed ID: 16446217
[TBL] [Abstract][Full Text] [Related]
4. Plasma biomarkers of myocardial fibrosis and remodeling in terminal heart failure patients supported by mechanical circulatory support devices.
Milting H; Ellinghaus P; Seewald M; Cakar H; Bohms B; Kassner A; Körfer R; Klein M; Krahn T; Kruska L; El Banayosy A; Kramer F
J Heart Lung Transplant; 2008 Jun; 27(6):589-96. PubMed ID: 18503956
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal assessment of inflammation in recipients of continuous-flow left ventricular assist devices.
Grosman-Rimon L; Jacobs I; Tumiati LC; McDonald MA; Bar-Ziv SP; Fuks A; Kawajiri H; Lazarte J; Ghashghai A; Shogilev DJ; Cherney DZ; Rao V
Can J Cardiol; 2015 Mar; 31(3):348-56. PubMed ID: 25746024
[TBL] [Abstract][Full Text] [Related]
6. Short-term mechanical unloading and reverse remodeling of failing hearts in children.
Mohapatra B; Vick GW; Fraser CD; Clunie SK; Towbin JA; Sinagra G; Vatta M
J Heart Lung Transplant; 2010 Jan; 29(1):98-104. PubMed ID: 19783184
[TBL] [Abstract][Full Text] [Related]
7. Decreased myocardial chromogranin a expression and colocalization with brain natriuretic peptide during reverse cardiac remodeling after ventricular unloading.
Wohlschlaeger J; von Winterfeld M; Milting H; El Banayosy A; Schmitz KJ; Takeda A; Takeda N; Azhari P; Schmid C; August C; Schmid KW; Baba HA
J Heart Lung Transplant; 2008 Apr; 27(4):442-9. PubMed ID: 18374882
[TBL] [Abstract][Full Text] [Related]
8. Myocardial size and fibrosis changes during left ventricular assist device support.
Yamada Y; Saito S; Nishinaka T; Yamazaki K
ASAIO J; 2012; 58(4):402-6. PubMed ID: 22739784
[TBL] [Abstract][Full Text] [Related]
9. Plasma neurohormone levels correlate with left ventricular functional and morphological improvement in LVAD patients.
Thompson LO; Skrabal CA; Loebe M; Lafuente JA; Roberts RR; Akgul A; Jones V; Bruckner BA; Thohan V; Noon GP; Youker KA
J Surg Res; 2005 Jan; 123(1):25-32. PubMed ID: 15652947
[TBL] [Abstract][Full Text] [Related]
10. Markers of inflammation in recipients of continuous-flow left ventricular assist devices.
Grosman-Rimon L; McDonald MA; Jacobs I; Tumiati LC; Pollock Bar-Ziv S; Shogilev DJ; Mociornita AG; Ghashghai A; Chruscinski A; Cherney DZ; Rao V
ASAIO J; 2014; 60(6):657-63. PubMed ID: 25232767
[TBL] [Abstract][Full Text] [Related]
11. B-Type Natriuretic Peptide Levels Predict Ventricular Arrhythmia Post Left Ventricular Assist Device Implantation.
Hellman Y; Malik AS; Lin H; Shen C; Wang IW; Wozniak TC; Hashmi ZA; Pickrell J; Jani M; Caccamo MA; Gradus-Pizlo I; Hadi A
Artif Organs; 2015 Dec; 39(12):1051-5. PubMed ID: 25864448
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA Expression in Myocardial Tissue and Plasma of Patients with End-Stage Heart Failure during LVAD Support: Comparison of Continuous and Pulsatile Devices.
Lok SI; de Jonge N; van Kuik J; van Geffen AJ; Huibers MM; van der Weide P; Siera E; Winkens B; Doevendans PA; de Weger RA; da Costa Martins PA
PLoS One; 2015; 10(10):e0136404. PubMed ID: 26430739
[TBL] [Abstract][Full Text] [Related]
13. Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support.
Lok SI; Winkens B; Goldschmeding R; van Geffen AJ; Nous FM; van Kuik J; van der Weide P; Klöpping C; Kirkels JH; Lahpor JR; Doevendans PA; de Jonge N; de Weger RA
Eur J Heart Fail; 2012 Nov; 14(11):1249-56. PubMed ID: 22843564
[TBL] [Abstract][Full Text] [Related]
14. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
[TBL] [Abstract][Full Text] [Related]
15. Cardiac molecular markers of programmed cell death are activated in end-stage heart failure patients supported by left ventricular assist device.
Prescimone T; Masotti S; D'Amico A; Caruso R; Cabiati M; Caselli C; Viglione F; Verde A; Del Ry S; Giannessi D
Cardiovasc Pathol; 2014; 23(5):272-82. PubMed ID: 24856512
[TBL] [Abstract][Full Text] [Related]
16. Expression of extracellular matrix genes during myocardial recovery from heart failure after left ventricular assist device support.
Felkin LE; Lara-Pezzi E; George R; Yacoub MH; Birks EJ; Barton PJ
J Heart Lung Transplant; 2009 Feb; 28(2):117-22. PubMed ID: 19201335
[TBL] [Abstract][Full Text] [Related]
17. Systemic Inflammatory Response Syndrome in End-Stage Heart Failure Patients Following Continuous-Flow Left Ventricular Assist Device Implantation: Differences in Plasma Redox Status and Leukocyte Activation.
Mondal NK; Sorensen EN; Pham SM; Koenig SC; Griffith BP; Slaughter MS; Wu ZJ
Artif Organs; 2016 May; 40(5):434-43. PubMed ID: 26416627
[TBL] [Abstract][Full Text] [Related]
18. Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group.
Maybaum S; Mancini D; Xydas S; Starling RC; Aaronson K; Pagani FD; Miller LW; Margulies K; McRee S; Frazier OH; Torre-Amione G;
Circulation; 2007 May; 115(19):2497-505. PubMed ID: 17485581
[TBL] [Abstract][Full Text] [Related]
19. Dynamics and prognostic role of galectin-3 in patients with advanced heart failure, during left ventricular assist device support and following heart transplantation.
Coromilas E; Que-Xu EC; Moore D; Kato TS; Wu C; Ji R; Givens R; Jorde UP; Takayama H; Naka Y; George I; Mancini D; Schulze PC
BMC Cardiovasc Disord; 2016 Jun; 16():138. PubMed ID: 27301475
[TBL] [Abstract][Full Text] [Related]
20. B-type natriuretic peptide levels and continuous-flow left ventricular assist devices.
Sareyyupoglu B; Boilson BA; Durham LA; McGregor CG; Daly RC; Redfield MM; Edwards BS; Frantz RP; Pereira NL; Park SJ
ASAIO J; 2010; 56(6):527-31. PubMed ID: 21245799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
